REM-422 is the first oral mRNA degrader of MYB demonstrating proof-of-concept in ACC. In this study, pharmacokinetic and pharmacodynamic analyses conirmed robust compound exposure in blood and target ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing defects that lead to Huntington's disease and link HD with other ...

How do cells ensure that the "blueprints" of genetic information-RNA are accurate and intact before they are exported from the nucleus to the cytoplasm for protein production? A study led by Professor ...

An experimental RNA-based therapy shows promise for ALS by preventing TDP-43 protein clumping. An international team of scientists has developed an RNA-based experimental medicine that has the ...